Patients with rare endocrine conditions have corresponding views on unmet needs in clinical research
- PMID: 33534110
- PMCID: PMC8016771
- DOI: 10.1007/s12020-021-02618-z
Patients with rare endocrine conditions have corresponding views on unmet needs in clinical research
Abstract
Purpose: European Reference Network on Rare Endocrine Conditions' (Endo-ERN) mission is to reduce and ultimately abolish inequalities in care for patients with rare endocrine conditions in Europe. This study assesses which themes related to rare endocrine conditions are prioritized by patients for clinical research.
Methods: A survey was developed, translated into 22 different European languages, and distributed to patients with rare endocrine conditions. Patients were asked to give priority scores to listed prespecified topics: fertility, heritability, tiredness, daily medicine intake, sleep quality, physical discomfort, and ability to work, partake in social life, and sports. They were also asked to suggest further important areas for research in open fields.
Results: After data cleaning, 1378 survey responses were analyzed. Most responses were received from Northern (47%) and Western Europeans (39%), while Southern (11%) and Eastern Europe (2%) were underrepresented. Respondents were most interested in research concerning ability to participate in social life and work. Patients suggested key areas to work: long-term side effects of medical treatments and quality of life. Some priorities differed between disease groups, both for prespecified and open topics and reflected aspects of patients' individual conditions.
Conclusions: With this large survey, Endo-ERN gained insight into patients' unmet needs in scientific research. Patients prioritized research on ability to work and participation in social activities, though needs differ between the disease groups. Clinical experts should incorporate the results of this survey into the design of future studies on rare endocrine conditions. We aim to utilize these results in designing patient-reported outcome measures for the disease areas covered by Endo-ERN.
Keywords: Endo-ERN; Endocrinology; Patient perspective; Rare disease; Research.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Perspectives of the European Society of Endocrinology (ESE) and the European Society of Paediatric Endocrinology (ESPE) on rare endocrine disease.Endocrine. 2021 Mar;71(3):539-541. doi: 10.1007/s12020-021-02652-x. Epub 2021 Mar 19. Endocrine. 2021. PMID: 33740222 Free PMC article. Review.
-
Introduction to Endo-ERN-scope and mission.Endocrine. 2021 Mar;71(3):537-538. doi: 10.1007/s12020-020-02602-z. Epub 2021 Jan 15. Endocrine. 2021. PMID: 33449294 Free PMC article.
-
Supporting international networks through platforms for standardised data collection-the European Registries for Rare Endocrine Conditions (EuRRECa) model.Endocrine. 2021 Mar;71(3):555-560. doi: 10.1007/s12020-021-02617-0. Epub 2021 Jan 29. Endocrine. 2021. PMID: 33512655 Free PMC article. Review.
-
An overview of clinical activities in Endo-ERN: the need for alignment of future network criteria.Eur J Endocrinol. 2020 Aug;183(2):141-148. doi: 10.1530/EJE-20-0197. Eur J Endocrinol. 2020. PMID: 32413847
-
CPMS-improving patient care in Europe via virtual case discussions.Endocrine. 2021 Mar;71(3):549-554. doi: 10.1007/s12020-021-02628-x. Epub 2021 Feb 2. Endocrine. 2021. PMID: 33528763 Free PMC article. Review.
Cited by
-
Mapping of the current transition of care practice for patients with pituitary disease at Endo-ERN reference centers.Endocr Connect. 2023 Jan 27;12(2):e220308. doi: 10.1530/EC-22-0308. Print 2023 Feb 1. Endocr Connect. 2023. PMID: 36524809 Free PMC article.
-
ENDO-ERN ON RARE ENDOCRINE CONDITIONS: Endo-ERN in its fifth year: a pinch of care, science, curiosity and new horizons.Endocr Connect. 2022 Mar 24;11(3):e220082. doi: 10.1530/EC-22-0082. Endocr Connect. 2022. PMID: 35175223 Free PMC article. No abstract available.
-
A critical evaluation of the EU-virtual consultation platform (CPMS) within the European Reference Network on Rare Endocrine Conditions.Endocr Connect. 2022 Oct 17;11(11):e220281. doi: 10.1530/EC-22-0281. Print 2022 Nov 1. Endocr Connect. 2022. PMID: 36112499 Free PMC article. Review.
-
Twenty years of newborn screening for congenital adrenal hyperplasia and congenital primary hypothyroidism - experiences from the DGKED/AQUAPE study group for quality improvement in Germany.Med Genet. 2022 May 7;34(1):29-40. doi: 10.1515/medgen-2022-2114. eCollection 2022 Apr. Med Genet. 2022. PMID: 38836017 Free PMC article.
-
The health and economic burden of rare endocrine disease: Often ignored, always important.J Glob Health. 2024 Dec 9;14:04249. doi: 10.7189/jogh.14.04249. J Glob Health. 2024. PMID: 39651662 Free PMC article.
References
-
- F. de Vries, M. Bruin, A. Cersosimo, C. N. van Beuzekom, S. F. Ahmed, R. P. Peeters, N. R. Biermasz, O. Hiort, A. M. Pereira. An overview of clinical activities in Endo-ERN: the need for alignment of future network criteria. Eur J Endocrinol. 183(2), 141–148 (2020) - PubMed
-
- Endo-ERN. Overview of specific expertise (2020), https://endo-ern.eu/activities/research-activities/
-
- Endo-ERN. Research activities (2020), https://endo-ern.eu/activities/research-activities/
-
- UNSD. UNSD methodology—geographic regions (2020), https://unstats.un.org/unsd/methodology/m49/
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
